康德萊(603987.SH):康德萊醫械H股首發申請已獲聯交所原則同意
格隆匯10月22日丨康德萊(603987.SH)公佈,公司控股子公司上海康德萊醫療器械股份有限公司(“康德萊醫械”)於2019年10月22日獲其保薦人交銀國際(亞洲)有限公司(“交銀國際”)告知,交銀國際已於當日收到香港聯交所發來的信函,原則上同意康德萊醫械遞交的首次公開發行H股股票並在香港聯交所主板上市的申請。康德萊醫械上市前尚需取得香港聯交所的最終批准。
此次發行境外上市外資股(H股)並申請在香港聯交所主板掛牌上市的聆訊後資料集於2019年10月22日在香港聯交所網站刊登並可供下載及查閲。該申請版本為康德萊醫械按照香港證券及期貨事務監察委員會及香港聯交所的要求刊發,為草擬版本,其並未定稿且所載資料可能會適時作出更新及變動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.